Clinical Trial Update: Stopping TSC Onset and Progression 2B: Sirolimus TSC Epilepsy Prevention Study [Phase 2]

View source ↗

Summary

Phase 2 trial investigating sirolimus for preventing onset and progression of epilepsy in tuberous sclerosis complex; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Tuberous Sclerosis Complex

Drugs mentioned

• Rapamune (sirolimus)

Snippet

Sponsor: Darcy Krueger | Conditions: Tuberous Sclerosis Complex, Epilepsy | Phase 2 | Status: RECRUITING